Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

Head and neck squamous cell carcinomas (HNSCCs) are aggressive diseases with a dismal patient prognosis. Despite significant advances in treatment modalities, the five-year survival rate in patients with HNSCC has improved marginally and therefore warrants a comprehensive understanding of the HNSCC biology. Alterations in the cellular and non-cellular components of the HNSCC tumor micro-environment (TME) play a critical role in regulating many hallmarks of cancer development including evasion of apoptosis, activation of invasion, metastasis, angiogenesis, response to therapy, immune escape mechanisms, deregulation of energetics, and therefore the development of an overall aggressive HNSCC phenotype. Cytokines and chemokines are small secretory proteins produced by neoplastic or stromal cells, controlling complex and dynamic cell–cell interactions in the TME to regulate many cancer hallmarks. This review summarizes the current understanding of the complex cytokine/chemokine networks in the HNSCC TME, their role in activating diverse signaling pathways and promoting tumor progression, metastasis, and therapeutic resistance development.

[1]  S. Batra,et al.  Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy , 2021, Signal Transduction and Targeted Therapy.

[2]  Liping Wang,et al.  Roles of IFN-γ in tumor progression and regression: a review , 2020, Biomarker research.

[3]  A. Birbrair,et al.  Pericyte in Oral Squamous Cell Carcinoma: A Systematic Review , 2020, Head and Neck Pathology.

[4]  A. Green,et al.  Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy , 2020, Frontiers in Cell and Developmental Biology.

[5]  Xi Yang,et al.  The interaction of interleukin-8 and PTEN inactivation promotes the malignant progression of head and neck squamous cell carcinoma via the STAT3 pathway , 2020, Cell Death & Disease.

[6]  A. Argiris,et al.  An update on angiogenesis targeting in head and neck squamous cell carcinoma , 2020, Cancers of the Head & Neck.

[7]  K. Schenke-Layland,et al.  The role of extracellular matrix in biomechanics and its impact on bioengineering of cells and 3D tissues. , 2019, Matrix biology : journal of the International Society for Matrix Biology.

[8]  Nayoung Kim,et al.  CXCR7 promotes migration and invasion in head and neck squamous cell carcinoma by upregulating TGF-β1/Smad2/3 signaling , 2019, Scientific Reports.

[9]  J. Bagan,et al.  Salivary Cytokines in patients with Head and Neck Cancer (HNC) treated with Radiotherapy , 2019, Journal of clinical and experimental dentistry.

[10]  P. Friedlander,et al.  Tumor necrosis factor-α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial- and non-mitochondrial-dependent pathways. , 2019, International journal of oncology.

[11]  J. Schlom,et al.  Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors , 2019, Journal of Immunotherapy for Cancer.

[12]  Li‐Wha Wu,et al.  Cancer‐associated fibroblast‐derived interleukin‐1β activates protumor C‐C motif chemokine ligand 22 signaling in head and neck cancer , 2019, Cancer science.

[13]  M. Gulubova,et al.  IL-6 Activities in the Tumour Microenvironment. Part 1 , 2019, Open access Macedonian journal of medical sciences.

[14]  M. Montès,et al.  New CXCR1/CXCR2 inhibitors represent an effective treatment for kidney or head and neck cancers sensitive or refractory to reference treatments , 2019, Theranostics.

[15]  J. Masumoto,et al.  The role of interleukin-1 in general pathology , 2019, Inflammation and regeneration.

[16]  B. Mroczko,et al.  Clinical Significance of Selected Chemokines in Thyroid Cancer , 2019, AntiCancer Research.

[17]  Michael Korrer,et al.  Phenotypical and functional analysis of natural killer cells from primary human head and neck squamous cell carcinomas , 2019, The Journal of Immunology.

[18]  M. Ergin,et al.  Role of T-helper 17 cell related cytokines in laryngeal cancer , 2019, The Journal of Laryngology & Otology.

[19]  Yan Cui,et al.  Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy , 2019, Front. Cell Dev. Biol..

[20]  P. Kubes,et al.  The Neutrophil's Role During Health and Disease. , 2019, Physiological reviews.

[21]  M. Masařík,et al.  Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review , 2019, Molecular Cancer.

[22]  C. R. Leemans,et al.  Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial , 2019, The Lancet.

[23]  B. Molon,et al.  Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization , 2018, International journal of molecular sciences.

[24]  Ge Zhou,et al.  Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma , 2018, British Journal of Cancer.

[25]  pYuChun Linp Cancer-associated fibroblast induced chemokine (C-C motif) ligand 11 contribute to the progression of head and neck cancer , 2018 .

[26]  Lun Zhang,et al.  TGF-β-induced STAT3 overexpression promotes human head and neck squamous cell carcinoma invasion and metastasis through malat1/miR-30a interactions. , 2018, Cancer letters.

[27]  Y. Hwang,et al.  IL-1β Induces Fascin Expression and Increases Cancer Invasion , 2018, AntiCancer Research.

[28]  W. Wen,et al.  Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis , 2018, Cancer Immunology, Immunotherapy.

[29]  H. J. Lee,et al.  Chemokine receptor CXCR7 expression, function and clinical implications in head and neck squamous cell carcinoma. , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[30]  R. Eri,et al.  Modulation of the CCR6-CCL20 Axis: A Potential Therapeutic Target in Inflammation and Cancer , 2018, Medicina.

[31]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[32]  F. Ihara,et al.  Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer , 2018, Front. Immunol..

[33]  Mihir B. Patel,et al.  Interleukin-6/STAT3 Signaling is Prominent and Associated with Reduced Overall Survival in p16 Negative Oropharyngeal Squamous Cell Carcinoma , 2018, Head and Neck Pathology.

[34]  Jenq-Lin Yang,et al.  Therapeutic Strategies for Targeting IL-33/ST2 Signalling for the Treatment of Inflammatory Diseases , 2018, Cellular Physiology and Biochemistry.

[35]  Xin-hua Liang,et al.  Transforming growth factor-β signaling in head and neck squamous cell carcinoma: Insights into cellular responses. , 2018, Oncology letters.

[36]  K. Ishibashi,et al.  Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , 2018, Oncoimmunology.

[37]  Zachary T. Giaccone,et al.  IL-6 Mediates Cross-Talk between Tumor Cells and Activated Fibroblasts in the Tumor Microenvironment. , 2018, Cancer research.

[38]  D. Laouini,et al.  Role of Human Macrophage Polarization in Inflammation during Infectious Diseases , 2018, International journal of molecular sciences.

[39]  M. Kaplan,et al.  IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers , 2018, OncoTargets and therapy.

[40]  G. Paludetti,et al.  IFN-γ and other serum cytokines in head and neck squamous cell carcinomas. , 2018, Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale.

[41]  Wei Liu,et al.  TGF-β1/TβRII/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages. , 2018, Biochemical and biophysical research communications.

[42]  T. Yoshimura The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally? , 2018, Cellular & Molecular Immunology.

[43]  Ge Zhou,et al.  Interferon-alpha enhances the antitumour activity of EGFR-targeted therapies by upregulating RIG-I in head and neck squamous cell carcinoma , 2018, British Journal of Cancer.

[44]  Manish R. Patel,et al.  A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors , 2017, Clinical Cancer Research.

[45]  Xiqiang Liu,et al.  Activation of adrenergic receptor β2 promotes tumor progression and epithelial mesenchymal transition in tongue squamous cell carcinoma , 2017, International journal of molecular medicine.

[46]  D. Loew,et al.  Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane , 2017, Nature Communications.

[47]  V. Budach,et al.  SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy , 2017, Clinical and translational radiation oncology.

[48]  A. Kulkarni,et al.  STAT3 Induces Immunosuppression by Upregulating PD-1/PD-L1 in HNSCC , 2017, Journal of dental research.

[49]  L. Pignataro,et al.  T-helper and T-regulatory cells modulation in head and neck squamous cell carcinoma , 2017, Oncoimmunology.

[50]  Ling-Feng Wang,et al.  IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC , 2017, Oncotarget.

[51]  P. Hammerman,et al.  Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck. , 2017, Oral oncology.

[52]  K. Shen,et al.  Recent progress in GM-CSF-based cancer immunotherapy. , 2017, Immunotherapy.

[53]  A. Santoni,et al.  Role of Distinct Natural Killer Cell Subsets in Anticancer Response , 2017, Front. Immunol..

[54]  I. Zaletel,et al.  Serum cytokine profile of laryngeal squamous cell carcinoma patients , 2017, The Journal of Laryngology & Otology.

[55]  Tieshan Teng,et al.  Neutrophils and Immunity: From Bactericidal Action to Being Conquered , 2017, Journal of immunology research.

[56]  T. Oyama,et al.  Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages , 2016, Oncotarget.

[57]  X. Cong,et al.  Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway , 2016, Oncotarget.

[58]  Hui-min Li,et al.  CCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma , 2016, Oncotarget.

[59]  K. Gibson-Corley,et al.  Interleukin-1 blockade overcomes erlotinib resistance in head and neck squamous cell carcinoma , 2016, Oncotarget.

[60]  Anping Li,et al.  The CXCL8-CXCR1/2 pathways in cancer , 2016, Cytokine & growth factor reviews.

[61]  R. Kalluri The biology and function of fibroblasts in cancer , 2016, Nature Reviews Cancer.

[62]  Ling-Feng Wang,et al.  IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway , 2016, Oncotarget.

[63]  G. Liao,et al.  TGFβ1-Smad3-Jagged1-Notch1-Slug signaling pathway takes part in tumorigenesis and progress of tongue squamous cell carcinoma. , 2016, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[64]  M. Quer,et al.  Expression of the CXCL12/CXCR4 chemokine axis predicts regional control in head and neck squamous cell carcinoma , 2016, European Archives of Oto-Rhino-Laryngology.

[65]  T. Teknos,et al.  Interleukin-6 role in head and neck squamous cell carcinoma progression , 2016, World journal of otorhinolaryngology - head and neck surgery.

[66]  A. Goy,et al.  Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies , 2016, Oncotarget.

[67]  Y. Okamoto,et al.  Invariant NKT cells are resistant to circulating CD15+ myeloid‐derived suppressor cells in patients with head and neck cancer , 2016, Cancer science.

[68]  Juan Wang,et al.  Modulation of IL-1β reprogrammes the tumor microenvironment to interrupt oral carcinogenesis , 2016, Scientific Reports.

[69]  M. Goldring,et al.  Laminins and Nidogens in the Pericellular Matrix of Chondrocytes: Their Role in Osteoarthritis and Chondrogenic Differentiation. , 2016, The American journal of pathology.

[70]  H. Worthington,et al.  Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors. , 2015, The Cochrane database of systematic reviews.

[71]  Seong-Jin Kim,et al.  Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer , 2015, Oncotarget.

[72]  M. Quer,et al.  Expression of IL-1α correlates with distant metastasis in patients with head and neck squamous cell carcinoma , 2015, Oncotarget.

[73]  P. Lin,et al.  Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer , 2015, Oncotarget.

[74]  J. Pollard,et al.  Therapeutic potential of chemokine signal inhibition for metastatic breast cancer , 2015, Pharmacological research.

[75]  R. Puri,et al.  Targeting of IL-4 and IL-13 receptors for cancer therapy. , 2015, Cytokine.

[76]  Ayyaz Ali Khan,et al.  Salivary Immunosuppressive Cytokines IL-10 and IL-13 Are Significantly Elevated in Oral Squamous Cell Carcinoma Patients , 2015, Cancer investigation.

[77]  C. Chen,et al.  IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer , 2015, Journal of cellular physiology.

[78]  G. Hu,et al.  New horizons in tumor microenvironment biology: challenges and opportunities , 2015, BMC Medicine.

[79]  F. J. Ahmad,et al.  Role of neurotransmitter Substance P in progression of oral squamous cell carcinoma. , 2015, Pathology, research and practice.

[80]  M. S. St John Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma , 2015, The Laryngoscope.

[81]  Liyu Liu,et al.  Enhanced Invasion of Metastatic Cancer Cells via Extracellular Matrix Interface , 2015, PloS one.

[82]  Maie A. John Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma. , 2015 .

[83]  Fa-Yu Liu,et al.  CCR7 regulates cell migration and invasion through MAPKs in metastatic squamous cell carcinoma of head and neck. , 2014, International journal of oncology.

[84]  S. Kondo,et al.  Expression of interleukin-33 is correlated with poor prognosis of patients with squamous cell carcinoma of the tongue. , 2014, Auris, nasus, larynx.

[85]  I. Herman,et al.  Pericyte contractility controls endothelial cell cycle progression and sprouting: insights into angiogenic switch mechanics. , 2014, American journal of physiology. Cell physiology.

[86]  D. Pennington,et al.  Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. , 2014, Biochimica et biophysica acta.

[87]  L. Bingle,et al.  The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour. , 2014, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[88]  K. Mills,et al.  Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines , 2014, Oncogene.

[89]  F. Giancotti Deregulation of cell signaling in cancer , 2014, FEBS letters.

[90]  Changfu Sun,et al.  Chemokine receptor 7 enhances cell chemotaxis and migration of metastatic squamous cell carcinoma of head and neck through activation of matrix metalloproteinase-9. , 2014, Oncology reports.

[91]  Å. Borg,et al.  Cancer-associated fibroblasts expressing CXCL14 rely upon NOS1-derived nitric oxide signaling for their tumor-supporting properties. , 2014, Cancer research.

[92]  Xia Li,et al.  A CCL2/ROS autoregulation loop is critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell carcinoma. , 2014, Carcinogenesis.

[93]  T. Andersson,et al.  Interleukin‐6 drives melanoma cell motility through p38α‐MAPK‐dependent up‐regulation of WNT5A expression , 2014, Molecular oncology.

[94]  T. Omori,et al.  CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma , 2014, BMC Cancer.

[95]  M. Young,et al.  Effect of the Premalignant and Tumor Microenvironment on Immune Cell Cytokine Production in Head and Neck Cancer , 2014, Cancers.

[96]  Hau-Ren Chen,et al.  Monocyte Chemotactic Protein 1 (MCP-1) Modulates Pro-Survival Signaling to Promote Progression of Head and Neck Squamous Cell Carcinoma , 2014, PloS one.

[97]  Kai-Ping Chang,et al.  Serum CXCL9 Levels Are Associated with Tumor Progression and Treatment Outcome in Patients with Nasopharyngeal Carcinoma , 2013, PloS one.

[98]  P. Bragado,et al.  TGFβ2 dictates disseminated tumour cell fate in target organs through TGFβ-RIII and p38α/β signalling , 2013, Nature Cell Biology.

[99]  Yaoh-Shiang Lin,et al.  The paracrine effect of cancer‐associated fibroblast‐induced interleukin‐33 regulates the invasiveness of head and neck squamous cell carcinoma , 2013, The Journal of pathology.

[100]  S. Koul,et al.  Role of p38 MAP Kinase Signal Transduction in Solid Tumors. , 2013, Genes & cancer.

[101]  D. Waugh,et al.  Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer , 2013, Pharmaceuticals.

[102]  Kai-Ping Chang,et al.  Serum levels of chemokine (C-X-C motif) ligand 9 (CXCL9) are associated with tumor progression and treatment outcome in patients with oral cavity squamous cell carcinoma. , 2013, Oral oncology.

[103]  C. Garlanda,et al.  Tumor associated macrophages and neutrophils in tumor progression , 2013, Journal of cellular physiology.

[104]  P. Xie,et al.  M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway , 2013, Laboratory Investigation.

[105]  C. Umbreit,et al.  SDF-1-CXCR4 axis: cell trafficking in the cancer stem cell niche of head and neck squamous cell carcinoma. , 2013, Oncology reports.

[106]  Wei Liu,et al.  Cancer-Associated Fibroblasts from Hepatocellular Carcinoma Promote Malignant Cell Proliferation by HGF Secretion , 2013, PloS one.

[107]  R. Shruthy,et al.  Immunohistochemical expression of basement membrane laminin in histological grades of oral squamous cell carcinoma: A semiquantitative analysis , 2013, Journal of oral and maxillofacial pathology : JOMFP.

[108]  M. Smyth,et al.  Molecular mechanisms of natural killer cell activation in response to cellular stress , 2013, Cell Death and Differentiation.

[109]  Pankaj Agarwal,et al.  Expression of type IV collagen in different histological grades of oral squamous cell carcinoma: an immunohistochemical study. , 2013, Journal of cancer research and therapeutics.

[110]  R. McLendon,et al.  Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth , 2013, Cell.

[111]  M. Muñoz,et al.  The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists , 2012, Peptides.

[112]  C. Chung,et al.  Inhibition of TGF-β Enhances the In Vivo Antitumor Efficacy of EGF Receptor–Targeted Therapy , 2012, Molecular Cancer Therapeutics.

[113]  S. Amin,et al.  Ah Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype , 2012, Molecular Cancer Research.

[114]  D. Conrad,et al.  Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity , 2012, The Journal of Immunology.

[115]  M. Fischer,et al.  New vessel formation in peritumoral area of squamous cell carcinoma of the head and neck , 2012, Head & neck.

[116]  Katsumasa Takahashi,et al.  Immunosuppressive activity of CD14+ HLA‐DR− cells in squamous cell carcinoma of the head and neck , 2012, Cancer science.

[117]  Christian Freudlsperger,et al.  TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers , 2012, Oncogene.

[118]  S-F Yang,et al.  Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. , 2012, Oral diseases.

[119]  Yun Hong,et al.  Expressions of CXCL12/CXCR4 in Oral Premalignant and Malignant Lesions , 2012, Mediators of inflammation.

[120]  A. Egloff,et al.  Chemokine Receptor 7 (CCR7) Gene Expression Is Regulated by NF-κB and Activator Protein 1 (AP1) in Metastatic Squamous Cell Carcinoma of Head and Neck (SCCHN)* , 2011, The Journal of Biological Chemistry.

[121]  I. Wistuba,et al.  STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous Carcinoma , 2011, Clinical Cancer Research.

[122]  J. Datta,et al.  IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway , 2011, Molecular Cancer Research.

[123]  T. Whiteside,et al.  Tumor‐derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation , 2011, International journal of cancer.

[124]  E. Crivellato,et al.  The role of pericytes in angiogenesis. , 2011, The International journal of developmental biology.

[125]  S. Quezada,et al.  Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication , 2011, Immunological reviews.

[126]  C. Akdis,et al.  Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. , 2011, The Journal of allergy and clinical immunology.

[127]  D. Bernabé,et al.  Stress hormones increase cell proliferation and regulates interleukin-6 secretion in human oral squamous cell carcinoma cells , 2011, Brain, Behavior, and Immunity.

[128]  K. Harrington,et al.  MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. , 2011, European journal of cancer.

[129]  T. Yen,et al.  Overexpression of macrophage inflammatory protein-3α in oral cavity squamous cell carcinoma is associated with nodal metastasis. , 2011, Oral oncology.

[130]  S. Malkoski,et al.  TGFβ signaling in head and neck squamous cell carcinoma , 2010, Oncogene.

[131]  Changfu Sun,et al.  The chemokine receptor 7 regulates cell adhesion and migration via beta1 integrin in metastatic squamous cell carcinoma of the head and neck. , 2010, Oncology reports.

[132]  R. Gladue,et al.  CCR1 antagonists: what have we learned from clinical trials. , 2010, Current topics in medicinal chemistry.

[133]  Darren R. Williams,et al.  Tumor‐stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7 , 2010, International journal of cancer.

[134]  Catherine C. Park,et al.  Breast cancer cells in three-dimensional culture display an enhanced radioresponse after coordinate targeting of integrin alpha5beta1 and fibronectin. , 2010, Cancer research.

[135]  C. Murdoch,et al.  Functional expression of the chemokine receptor XCR1 on oral epithelial cells , 2010, The Journal of pathology.

[136]  Kristian Pietras,et al.  Hallmarks of cancer: interactions with the tumor stroma. , 2010, Experimental cell research.

[137]  J. Steinke,et al.  Immunologic messenger molecules: cytokines, interferons, and chemokines. , 2010, The Journal of allergy and clinical immunology.

[138]  T. Nokes,et al.  Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics , 2009, Thrombosis and Haemostasis.

[139]  Mikala Egeblad,et al.  Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling , 2009, Cell.

[140]  Shun-Fa Yang,et al.  Contribution of genetic polymorphisms of stromal cell–derived factor‐1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer , 2009, Head & neck.

[141]  L. J. Eldik,et al.  Inflammatory cytokines stimulate the chemokines CCL2/MCP-1 and CCL7/MCP-7 through NFκB and MAPK dependent pathways in rat astrocytes , 2009, Brain Research.

[142]  Y. Oike,et al.  Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma , 2009, Clinical Cancer Research.

[143]  J. Chuang,et al.  CCL5/CCR5 axis promotes the motility of human oral cancer cells , 2009, Journal of cellular physiology.

[144]  Z. Shang,et al.  Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma. , 2009, Oral oncology.

[145]  F. Esteban,et al.  A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma. , 2009, Anticancer research.

[146]  Panomwat Amornphimoltham,et al.  Tumor–stroma interactions influence cytokine expression and matrix metalloproteinase activities in paired primary and metastatic head and neck cancer cells , 2009, Cell biology international.

[147]  Z. Shang,et al.  Expression of beta2-adrenergic receptor in oral squamous cell carcinoma. , 2008, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[148]  C. Gleissner,et al.  Platelet Chemokines in Vascular Disease , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[149]  Yong Lin,et al.  Tumor necrosis factor and cancer, buddies or foes? , 2008, Acta Pharmacologica Sinica.

[150]  Michelle Collazo,et al.  Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice1 , 2008, The Journal of Immunology.

[151]  M. Brown,et al.  NF-κB in carcinoma therapy and prevention , 2008 .

[152]  E. Prakash,et al.  CXCL12/CXCR4 promotes laryngeal and hypopharyngeal squamous cell carcinoma metastasis through MMP-13-dependent invasion via the ERK1/2/AP-1 pathway. , 2008, Carcinogenesis.

[153]  D. Vignali,et al.  How regulatory T cells work , 2008, Nature Reviews Immunology.

[154]  S. Vandenberg,et al.  HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. , 2008, Cancer cell.

[155]  J. Nör,et al.  Endothelial cells enhance tumor cell invasion through a crosstalk mediated by CXC chemokine signaling. , 2008, Neoplasia.

[156]  P. Cohen,et al.  IL-1β-stimulated activation of ERK1/2 and p38α MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-α in HeLa cells , 2008 .

[157]  F. Autschbach,et al.  Sulfated Glycosphingolipid as Mediator of Phagocytosis: SM4s Enhances Apoptotic Cell Clearance and Modulates Macrophage Activity1 , 2007, The Journal of Immunology.

[158]  F. Cunha,et al.  Dual role of CCL3/CCR1 in oral squamous cell carcinoma: implications in tumor metastasis and local host defense. , 2007, Oncology reports.

[159]  R. Strieter,et al.  Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. , 2007, Cancer research.

[160]  J. Siegfried,et al.  Multiple Cytokine and Growth Factor Serum Biomarkers Predict Therapeutic Response and Survival in Advanced-Stage Head and Neck Cancer Patients , 2007, Clinical Cancer Research.

[161]  S. Zheng,et al.  IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells1 , 2007, The Journal of Immunology.

[162]  Faina Linkov,et al.  Early Detection of Head and Neck Cancer: Development of a Novel Screening Tool Using Multiplexed Immunobead-Based Biomarker Profiling , 2007, Cancer Epidemiology Biomarkers & Prevention.

[163]  Paolo P. Provenzano,et al.  Collagen reorganization at the tumor-stromal interface facilitates local invasion , 2006, BMC medicine.

[164]  B. Han,et al.  Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? , 2006, Cancer and Metastasis Reviews.

[165]  P. Hwu,et al.  Improving Antitumor Immune Responses by Circumventing Immunoregulatory Cells and Mechanisms , 2006, Clinical Cancer Research.

[166]  A. Ziober,et al.  The extracellular matrix in oral squamous cell carcinoma: Friend or foe? , 2006, Head & neck.

[167]  C. Snyderman,et al.  Chemokine receptors in head and neck cancer: Association with metastatic spread and regulation during chemotherapy , 2006, International journal of cancer.

[168]  T. Salo,et al.  Collagen XVII promotes integrin-mediated squamous cell carcinoma transmigration--a novel role for alphaIIb integrin and tirofiban. , 2006, Experimental cell research.

[169]  W. A. Yeudall,et al.  Down-regulation of CXCL5 inhibits squamous carcinogenesis. , 2006, Cancer research.

[170]  M. Burdick,et al.  Cancer CXC chemokine networks and tumour angiogenesis. , 2006, European journal of cancer.

[171]  S. Fujieda,et al.  Oral and oropharyngeal squamous cell carcinomas expressing CCR7 have poor prognoses. , 2006, Auris, nasus, larynx.

[172]  M. Burdick,et al.  CXC chemokines in angiogenesis , 2000, Journal of leukocyte biology.

[173]  Steven Song,et al.  The role of pericytes in blood-vessel formation and maintenance. , 2005, Neuro-oncology.

[174]  C. Van Waes,et al.  A pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with head and neck squamous cell carcinoma , 2005, Head & neck.

[175]  T. Giordano,et al.  Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. , 2005, Cancer cell.

[176]  Shaomeng Wang,et al.  Bcl-2 acts in a proangiogenic signaling pathway through nuclear factor-kappaB and CXC chemokines. , 2005, Cancer research.

[177]  D. Landsittel,et al.  Multiplexed Analysis of Serum Cytokines as Biomarkers in Squamous Cell Carcinoma of the Head and Neck Patients , 2005, The Laryngoscope.

[178]  C. Pothoulakis,et al.  Metalloproteinases and Transforming Growth Factor-α Mediate Substance P-induced Mitogen-activated Protein Kinase Activation and Proliferation in Human Colonocytes* , 2004, Journal of Biological Chemistry.

[179]  S. Zucker,et al.  CXCR4-mediated adhesion and MMP-9 secretion in head and neck squamous cell carcinoma. , 2004, Cancer letters.

[180]  E. Oldfield,et al.  Human Platelet Dense Granules Contain Polyphosphate and Are Similar to Acidocalcisomes of Bacteria and Unicellular Eukaryotes* , 2004, Journal of Biological Chemistry.

[181]  R. Moll,et al.  CD34+ fibrocytes, α-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx , 2004, Virchows Archiv.

[182]  J. Siegfried,et al.  Lung cancer-derived bombesin-like peptides down-regulate the generation and function of human dendritic cells , 2003, Journal of Neuroimmunology.

[183]  H. Yoshida,et al.  Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. , 2003, Experimental cell research.

[184]  Holger Gerhardt,et al.  Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.

[185]  M. Ratajczak,et al.  CXCR4–SDF-1 Signalling, Locomotion, Chemotaxis and Adhesion , 2003, Journal of Molecular Histology.

[186]  Calman Prussin,et al.  IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.

[187]  J. Steinke,et al.  2. Cytokines and chemokines. , 2003, The Journal of allergy and clinical immunology.

[188]  J. Folkman Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.

[189]  A. Enk,et al.  Immature, but not inactive: the tolerogenic function of immature dendritic cells , 2002, Immunology and cell biology.

[190]  M. Wadhwa,et al.  Chemokine/chemokine receptor nomenclature. , 2002, Journal of immunological methods.

[191]  Gerold Schuler,et al.  Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity? , 2002, Trends in immunology.

[192]  B. Mian,et al.  Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. , 2002, The American journal of pathology.

[193]  P. Dhawan,et al.  Role of CXCL1 in tumorigenesis of melanoma , 2002, Journal of leukocyte biology.

[194]  F. Balkwill,et al.  The role of cytokines in the epithelial cancer microenvironment. , 2002, Seminars in cancer biology.

[195]  B. H. Shah,et al.  Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine. , 2001, Experimental & Molecular Medicine.

[196]  Michel C. Nussenzweig,et al.  Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo , 2001, The Journal of experimental medicine.

[197]  J. Cruse,et al.  10 - Cytokines and Chemokines , 2004 .

[198]  D J Mooney,et al.  Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. , 2001, Cancer research.

[199]  T. Tlsty,et al.  Know thy neighbor: stromal cells can contribute oncogenic signals. , 2001, Current opinion in genetics & development.

[200]  M. Levite Nerve‐Driven Immunity: The Direct Effects of Neurotransmitters on T‐Cell Function , 2000, Annals of the New York Academy of Sciences.

[201]  H. Nakshatri,et al.  Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. , 1999, Biochemical and biophysical research communications.

[202]  D. Mooney,et al.  Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. , 1999, The American journal of pathology.

[203]  A. Luster,et al.  Chemokines--chemotactic cytokines that mediate inflammation. , 1998, The New England journal of medicine.

[204]  M. Young,et al.  Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells , 1997, International journal of cancer.

[205]  D. Kreutzer,et al.  Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. , 1997, American journal of surgery.

[206]  M. Shurin Dendritic cells presenting tumor antigen , 1996, Cancer Immunology, Immunotherapy.

[207]  J. Faivre,et al.  Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[208]  P. Reade,et al.  The prognosis of oral mucosal squamous cell carcinomas: a comparison of clinical and histopathological grading and of laminin and type IV collagen staining. , 1996, Australian dental journal.

[209]  M J Metzelaar,et al.  CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. , 1991, The Journal of biological chemistry.

[210]  D. Winn,et al.  Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.

[211]  P. Singh,et al.  Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis. , 1986, Cellular immunology.

[212]  A. Le,et al.  Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells. , 2018, Advances in experimental medicine and biology.

[213]  V. Weaver,et al.  The Physical and Biochemical Properties of the Extracellular Matrix Regulate Cell Fate. , 2018, Current topics in developmental biology.

[214]  Muhammad Sohail Zafar,et al.  Role of Salivary Biomarkers in Oral Cancer Detection. , 2018, Advances in clinical chemistry.

[215]  G. Wolf,et al.  Tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. , 2015, Oral oncology.

[216]  Patrice Ravel,et al.  PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. , 2013, Cancer research.

[217]  S. Hunt,et al.  Endothelin‐1 stimulates motility of head and neck squamous carcinoma cells by promoting stromal–epithelial interactions , 2012, International journal of cancer.

[218]  F. Levi-Schaffer,et al.  Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells. , 2012, Lung cancer.

[219]  R. Ferris,et al.  Defective NF-κB signaling in metastatic head and neck cancer cells leads to enhanced apoptosis by double-stranded RNA. , 2012, Cancer research.

[220]  A. Stepan,et al.  VEGF and his R1 and R2 receptors expression in mast cells of oral squamous cells carcinomas and their involvement in tumoral angiogenesis. , 2011, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[221]  Yong Li,et al.  Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas. , 2011, Asian Pacific journal of cancer prevention : APJCP.

[222]  A. Liston,et al.  Regulatory T Cells , 2011, Methods in Molecular Biology.

[223]  S. Goodman,et al.  Immunohistochemical analysis of integrins αvβ3, αvβ5 and α5β1, and their ligands, fibrinogen, fibronectin, osteopontin and vitronectin, in frozen sections of human oral head and neck squamous cell carcinomas. , 2011, Experimental and therapeutic medicine.

[224]  Ruud H. Brakenhoff,et al.  The molecular biology of head and neck cancer , 2011, Nature Reviews Cancer.

[225]  Fei Xing,et al.  Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.

[226]  A. Stepan,et al.  Immunohistochemical characterization of tumoral vessels in oral squamous cell carcinoma. , 2008, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.

[227]  M. Brown,et al.  NF-kappaB in carcinoma therapy and prevention. , 2008, Expert opinion on therapeutic targets.

[228]  P. Cohen,et al.  IL-1beta-stimulated activation of ERK1/2 and p38alpha MAPK mediates the transcriptional up-regulation of IL-6, IL-8 and GRO-alpha in HeLa cells. , 2008, Cellular signalling.

[229]  R. Moll,et al.  CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. , 2004, Virchows Archiv : an international journal of pathology.

[230]  M. Oka,et al.  An immunohistochemical study of the extracellular matrix in oral squamous cell carcinoma and its association with invasive and metastatic potential , 2004, Virchows Archiv.

[231]  D. Metcalfe,et al.  4. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.

[232]  M. Cameron,et al.  Cytokines and chemokines--their receptors and their genes: an overview. , 2003, Advances in experimental medicine and biology.

[233]  C. Muro-Cacho,et al.  Expression of transforming growth factor beta type II receptors in head and neck squamous cell carcinoma. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[234]  A. S. Pak,et al.  Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.